RASSF1 and neoplasm: Typically, abnormal DNA methylation in tumor cells results in the inhibition of genes related to cell cycle regulation, DNA repair, and apoptosis.[43] Studies have found high methylation of genes such as p16, p15, and RASSF1A in early-stage LIHC, suggesting the potential of DNA methylation as a biomarker for early LIHC.